Clinical Trial Update: Evaluation of Safety, Efficacy and Thermogenesis-induction of RZL-012 in Overweight and Obese Volunteers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety, efficacy, and thermogenesis induction of RZL-012 in overweight/obese volunteers has completed with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• RZL-012

Snippet

Sponsor: Raziel Therapeutics Ltd. | Conditions: Obesity, Weight Loss | Phase 2 | Status: COMPLETED | Results posted: 2019-08-21